Bangalore: Biocon CMD Kiran Mazumdar-Shaw
today termed the government's moratorium on commercialisation
of Bt Brinjal as a "big setback" for biotechnology saying that
investment in agri-biotech research would be adversely
impacted.
"This decision is certainly a big setback for
biotechnology and I am afraid it will thwart further
investment in agri-biotech research," she told PTI.
However, if the decision is due to the need for more
data, she was okay with the decision.
"Regulators can always choose to ask for more data if
there is a concern expressed. This is quite normal even in the
case of drug approvals," Mazumdar-Shaw said.
"However, I am disappointed that Bt technology is not
better accepted after the success of Bt cotton," he added.
PTI
First Published: Tuesday, February 09, 2010, 21:08